Robert A. Hegele

Robert A. Hegele

Robarts Research Institute, Western University

Affiliated withWestern University

Research Area

Biography

Robert A. Hegele has not added Biography.
If you are Robert A. Hegele and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Publication title

Cited by 41

2018

Other Publications

Article
Year
Clinical equivalence of proprietary and generic atorvastatin in lipid clinic patients.

The Canadian journal of cardiology| PubMed ID: 22840301

2013
Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib.

Drug design, development and therapy| PubMed ID: 23055695

2012
Hypertriglyceridemia.

Nutrients| PubMed ID: 23525082

2013
2013
2014
2014
2014
2014
Inducing thyrotoxicosis in the liver to treat raised cholesterol.

The lancet. Diabetes & endocrinology| PubMed ID: 24731675

2014
2015
2014
Exome sequencing: new insights into lipoprotein disorders.

Current cardiology reports| PubMed ID: 24893940

2014
2014
Is plant-based cardioprotection evidence-based?

The Canadian journal of cardiology| PubMed ID: 25138482

2014
2015
Treatment of severe hypertriglyceridaemia--authors' reply.

The lancet. Diabetes & endocrinology| PubMed ID: 25439460

2014
The effect of infrequent low-dose rosuvastatin on the lipid profile.

The Canadian journal of cardiology| PubMed ID: 25442436

2014
2014
Congenital sucrase-isomaltase deficiency: identification of a common Inuit founder mutation.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne| PubMed ID: 25452324

2015
Doctor my eyes: a statin-cataract connection?

The Canadian journal of cardiology| PubMed ID: 25475455

2014
2014
Hypertriglyceridemia in the genomic era: a new paradigm.

Endocrine reviews| PubMed ID: 25554923

2015
2014
2015
HDL re-examined.

Current opinion in lipidology| PubMed ID: 25692348

2015
2015
Chylomicronaemia--current diagnosis and future therapies.

Nature reviews. Endocrinology| PubMed ID: 25732519

2015
The new dyslipidemia guidelines: what is the debate?

The Canadian journal of cardiology| PubMed ID: 25816728

2015
Cardiology patient page. Statin intolerance.

Circulation| PubMed ID: 25825402

2015
2015
2015
Incident Diabetes With Statins: Biology, Artifact, or Both?

The Canadian journal of cardiology| PubMed ID: 26211707

2015
2016
2015
Trial Watch: Antisenses working overtime in lipids.

Nature reviews. Endocrinology| PubMed ID: 26303603

2015
2015
2015
2015
Combined hyperlipidemia: familial but not (usually) monogenic.

Current opinion in lipidology| PubMed ID: 26709473

2016
Novel therapeutics in hypertriglyceridemia.

Current opinion in lipidology| PubMed ID: 26780002

2015
2016
2016
Improving the Monitoring and Care of Patients With Familial Hypercholesterolemia.

Journal of the American College of Cardiology| PubMed ID: 26988948

2016
Pharmacogenetics of Lipid-Lowering Agents: Precision or Indecision Medicine?

Current atherosclerosis reports| PubMed ID: 26993470

2016
2016
2016
Rare Genetic Variants and High-Density Lipoprotein: Marching to a Different Drum.

Arteriosclerosis, thrombosis, and vascular biology| PubMed ID: 27127203

2016
Proprietary Considerations in the Use of Cardiovascular Genetic Data.

The Canadian journal of cardiology| PubMed ID: 27166076

2016
2016
2016
2016
2016
2016
2016
PCSK9: Regulation and Target for Drug Development for Dyslipidemia.

Annual review of pharmacology and toxicology| PubMed ID: 27575716

2017
2016
New oral agents for treating dyslipidemia.

Current opinion in lipidology| PubMed ID: 27676196

2016
Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically.

Arteriosclerosis, thrombosis, and vascular biology| PubMed ID: 27765764

2016
Lomitapide for the treatment of hypertriglyceridemia.

Expert opinion on investigational drugs| PubMed ID: 27785928

2016
Seeking 'meta guidelines' for lipids.

European journal of preventive cardiology| PubMed ID: 27807189

2017
PCSK9 inhibition and diabetes: turning to Mendel for clues.

The lancet. Diabetes & endocrinology| PubMed ID: 27939390

2017
2017
2017
The Ontario Neurodegenerative Disease Research Initiative (ONDRI).

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques| PubMed ID: 28003035

2017
Clinical utility gene card for: Sitosterolaemia.

European journal of human genetics : EJHG| PubMed ID: 28029149

2017
Genetics for the Identification of Lipid Targets Beyond PCSK9.

The Canadian journal of cardiology| PubMed ID: 28109622

2017
Variants in ANGPTL4 and the Risk of Coronary Artery Disease.

The New England journal of medicine| PubMed ID: 28112898

2016
2017
2017
2017
Barriers to the Implementation of Lipoprotein Apheresis in Canada.

The Canadian journal of cardiology| PubMed ID: 28232020

2017
Genetics of Lipid and Lipoprotein Disorders and Traits.

Current genetic medicine reports| PubMed ID: 28286704

2016
2017
2017
Insulin affordability.

The lancet. Diabetes & endocrinology| PubMed ID: 28434485

2017
2017
PCSK9 inhibitors: smooth sailing or a little turbulence ahead?

The lancet. Diabetes & endocrinology| PubMed ID: 28483371

2017
Recent advances in genetic testing for familial hypercholesterolemia.

Expert review of molecular diagnostics| PubMed ID: 28524730

2017
Genetics of Triglycerides and the Risk of Atherosclerosis.

Current atherosclerosis reports| PubMed ID: 28534127

2017
Clinical utility gene card for: Tangier disease.

European journal of human genetics : EJHG| PubMed ID: 28537273

2017
Lomitapide for the treatment of hypercholesterolemia.

Expert opinion on pharmacotherapy| PubMed ID: 28598687

2017
Tools for Enhancement and Quality Improvement of Peer Assessment and Clinical Care in Endocrinology and Metabolism.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry| PubMed ID: 28739080

2017
2018
2017
2017
2017
2017
Recent Advances in the Genetics of Atherothrombotic Disease and Its Determinants.

Arteriosclerosis, thrombosis, and vascular biology| PubMed ID: 28954809

2017
2017
2017
2018
OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics| PubMed ID: 29080331

2018
Food Effect on Rosuvastatin Disposition and Low-Density Lipoprotein Cholesterol.

Clinical pharmacology and therapeutics| PubMed ID: 29218707

2017
2016
2018
Nutraceuticals in 2017: Nutraceuticals in endocrine disorders.

Nature reviews. Endocrinology| PubMed ID: 29286047

2018
2018
Learning From Patients With Ultrarare Conditions: Cholesterol Hoof Beats.

Journal of the American College of Cardiology| PubMed ID: 29348021

2018
2018
Whole genome sequencing in the clinic: empowerment or too much information?

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne| PubMed ID: 29431109

2018
2017
Fatty liver in a non-obese patient.

Paediatrics & child health| PubMed ID: 29479178

2017
Complex genetic architecture in severe hypobetalipoproteinemia.

Lipids in health and disease| PubMed ID: 29540175

2018